FDA Warning Letter — Frontida BioPharm Inc
The FDA took a Warning Letter action against Frontida BioPharm Inc on August 15, 2016 (Philadelphia, PA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Frontida BioPharm Inc
- Date
- August 15, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Philadelphia, PA (United States)